In a report released yesterday, Elyse Shapiro from Canaccord Genuity maintained a Hold rating on Mayne Pharma Group (MAYNF – Research Report), with a price target of A$7.40. The company’s shares closed last Tuesday at $4.19.

Shapiro covers the Healthcare sector, focusing on stocks such as Mayne Pharma Group, Nanosonics Limited, and Neuren Pharmaceuticals Limited. According to TipRanks, Shapiro has an average return of -11.6% and a 35.82% success rate on recommended stocks.

The word on The Street in general, suggests a Hold analyst consensus rating for Mayne Pharma Group with a $4.80 average price target.

MAYNF market cap is currently $363.5M and has a P/E ratio of -4.12.